Insider Trading & Ownership - Martin Samuel Bates

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Martin Samuel Bates
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-06-14
Sale
2024-06-18
4:05 pm
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP AND CFO
17,172$35.42$608,31591,757
(Direct)
View
2024-05-30
Sale
2024-06-03
4:05 pm
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP AND CFO
35,000$34.05$1,191,775105,728
(Direct)
View
2022-08-11
Sale
2022-08-15
4:16 pm
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP AND CFO
20,000$36.52$730,48545,406
(Direct)
View
2021-12-23
Sale
2021-12-28
4:02 pm
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP and CFO
9,500$42$399,00058,329
(Direct)
View
2021-11-15
Sale
2021-11-17
4:02 pm
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP and CFO
9,500$43.57$413,88367,829
(Direct)
View
2021-08-10
Sale
2021-08-12
10:00 am
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP and CFO
2,738$45.25$123,89577,329
(Direct)
View
2020-06-09
Purchase
2020-06-10
07:55 am
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP and CFO
9,750$3.05$29,73810,735
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-14
Exercise
2024-06-18
4:05 pm
N/A
N/A
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP AND CFO
3,201$9.016591,757
(Direct)
View
2024-06-14
Exercise
2024-06-18
4:05 pm
N/A
2028-06-13
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP AND CFO
20,169$091,757
(Direct)
View
2024-06-14
Exercise
2024-06-18
4:05 pm
N/A
N/A
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP AND CFO
16,968$10.3891,757
(Direct)
View
2024-06-13
Option Award
2024-06-17
4:13 pm
2025-06-13
2034-06-13
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP AND CFO
81,000$081,000
(Direct)
View
2024-05-30
Exercise
2024-06-03
4:05 pm
N/A
2030-06-18
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP AND CFO
25,000$0105,728
(Direct)
View
2024-05-30
Exercise
2024-06-03
4:05 pm
N/A
N/A
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP AND CFO
25,000$10.38105,728
(Direct)
View
2024-01-02
Exercise
2024-01-04
4:05 pm
N/A
2029-06-19
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP AND CFO
10,750$035,128
(Direct)
View
2024-01-02
Exercise
2024-01-04
4:05 pm
N/A
N/A
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP AND CFO
10,750$2.7835,128
(Direct)
View
2023-06-15
Option Award
2023-06-20
4:17 pm
2024-06-15
2033-06-15
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP AND CFO
80,000$080,000
(Direct)
View
2022-08-11
Exercise
2022-08-15
4:16 pm
N/A
N/A
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP AND CFO
6,329$9.016545,406
(Direct)
View
2022-08-11
Exercise
2022-08-15
4:16 pm
N/A
2028-06-13
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP AND CFO
20,000$045,406
(Direct)
View
2022-08-12
Exercise
2022-08-15
4:16 pm
N/A
N/A
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP AND CFO
13,671$2.7845,406
(Direct)
View
2022-06-16
Option Award
2022-06-17
4:13 pm
2023-06-16
2032-06-16
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP AND CFO
85,000$085,000
(Direct)
View
2021-12-23
Exercise
2021-12-28
4:02 pm
N/A
N/A
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP and CFO
3,250$9.016558,329
(Direct)
View
2021-12-23
Exercise
2021-12-28
4:02 pm
N/A
2028-06-13
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP and CFO
7,000$058,329
(Direct)
View
2021-12-23
Exercise
2021-12-28
4:02 pm
N/A
N/A
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP and CFO
3,750$2.7858,329
(Direct)
View
2021-11-15
Exercise
2021-11-17
4:02 pm
N/A
N/A
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP and CFO
3,250$9.016567,829
(Direct)
View
2021-11-15
Exercise
2021-11-17
4:02 pm
N/A
2028-06-13
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP and CFO
7,000$067,829
(Direct)
View
2021-11-15
Exercise
2021-11-17
4:02 pm
N/A
N/A
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP and CFO
3,750$2.7867,829
(Direct)
View
2021-08-10
Exercise
2021-08-12
10:00 am
N/A
N/A
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP and CFO
10,302$9.016577,329
(Direct)
View
2021-08-10
Exercise
2021-08-12
10:00 am
N/A
2028-06-13
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP and CFO
21,381$077,329
(Direct)
View
2021-08-10
Exercise
2021-08-12
10:00 am
N/A
N/A
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP and CFO
11,079$2.7877,329
(Direct)
View
2021-06-17
Option Award
2021-06-21
4:26 pm
2022-06-17
2031-06-17
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP and CFO
85,000$085,000
(Direct)
View
2020-06-18
Option Award
2020-06-19
08:07 am
2021-06-18
2030-06-18
Celldex Therapeutics Inc.CLDXMartin Samuel Bates
SVP and CFO
105,600$0105,600
(Direct)
View